✦ LIBER ✦

Use of Positron Emission Tomography to Target Prostate Cancer Gene Therapy by Oncolytic Herpes Simplex Virus

✍ Scribed by Michael Mullerad; David P. Eisenberg; Timothy J. Akhurst; Prasad S. Adusumilli; Christopher C. Riedl; Amit Bhargava; Mithat Gonen; Ronald Finn; Peter T. Scardino; Yuman Fong

Book ID: 106571244
Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 391 KB
Volume: 8
Category: Article
ISSN: 1536-1632
DOI: 10.1007/s11307-005-0028-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imaging progress of herpes simplex virus

Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography

✍ Yaghoubi, Shahriar S; Barrio, Jorge R; Namavari, Mohammad; Satyamurthy, Nagichet 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 381 KB

Imaging in vivo herpes simplex virus thy

Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [18F]FHPG

✍ Roland Hustinx; Chyng-Yann Shiue; Abass Alavi; Douglas McDonald; Grace G. Shiue; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 218 KB

Immunotherapy of murine prostate cancer

Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy

✍ Pandha, Hardev; Eaton, Jonathan; Greenhalgh, Rebecca; Soars, Diane; Dalgleish, A 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 165 KB

Adenovirus-mediated herpes simplex virus

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

✍ Simon J. Hall; Steven E. Mutchnik; Shu-Hsia Chen; Savio L.C. Woo; Timothy C. Tho 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 106 KB 👁 2 views

It is critical to develop new therapies, such as gene therapy, which can impact on both local and metastatic prostate cancer progression. We have developed an orthotopic mouse model of metastatic prostate cancer using a cell line (RM-1) derived from the mouse prostate reconstitution (MPR) model syst